RBC Capital downgrades Regis Healthcare stock rating on higher costs

RBC Capital downgraded Regis Healthcare Ltd. (ASX:REG) from Outperform to Sector Perform, concurrently lowering its price target to AUD8.25 from AUD8.75. This adjustment follows Regis Healthcare's FY25 results, which, despite exceeding consensus expectations, fell short of RBC Capital's forecasts, primarily due to higher staffing and new facility development costs. RBC indicated that the positive outlook for aged care demand is now fully reflected in the company's share price, suggesting minimal total shareholder return potential.

Analysis

RBC Capital has downgraded Regis Healthcare Ltd. (ASX:REG) to Sector Perform from Outperform and reduced its price target to AUD8.25 from AUD8.75. The revision follows Regis Healthcare's FY25 financial results, which, despite surpassing consensus expectations for revenue and net profit after tax, fell short of RBC's internal forecasts. The primary drivers for the downgrade are identified as higher-than-anticipated staffing costs and expenses associated with the development of new facilities. While RBC acknowledges the strong underlying demand for aged care services, its core thesis is that this positive long-term outlook is now fully priced into the company's valuation. The new price target suggests minimal total shareholder return, justifying the neutral stance and indicating that near-term catalysts for outperformance have diminished due to operational cost pressures.

Key Decisions for Investors

• Given the downgrade and RBC's assessment that the stock is fully valued, investors holding Regis Healthcare should re-evaluate their positions, as near-term upside appears limited according to this analysis.
• Prospective investors should exercise caution, as the revised AUD8.25 price target implies minimal returns and suggests waiting for a more favorable entry point or evidence of margin improvement.
• Traders and portfolio managers should closely monitor the company's ability to manage escalating staffing and development costs, as these operational headwinds are the central reason for the downgrade despite results beating market consensus.